RadarScreener › JAGX

JAGX

Jaguar Health, Inc.
Nasdaq · Pharmaceutical Preparations · EDGAR filings (CIK 1585608) · 11 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

Reverse splits are how companies cure bid-price deficiencies; under 2026 rules they get one per 12 months.

Radar 63 (elevated attention) · dilution pressure high · listing risk elevated · governance risk elevated · runway 3.7 mo · strongest signal: Late filing (NT) (Aug 14, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

63Radar · attention score (0–100)
73Dilution pressure · financing + balance sheet
53Listing risk · exchange standards
49Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on JAGX
Alerts
One email the morning JAGX files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for JAGX back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 985 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$7.3Mcash + short-term investments as of Mar 31, 2026
3.7 moestimated runway (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts])
n/astockholders' equity
$3.8Mpublic float (10-K cover)
n/ashares outstanding

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 138 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Aug 14, 2026 Late filing (NT) NT 10-Q filed 2026-08-14 filing 49
Aug 3, 2026 Reverse split “reverse split” language in DEF 14A (DEF 14A) filed 2026-08-03 filing 27
Jul 27, 2026 Offering (424B) 424B3 prospectus supplement 2026-07-27; 1 prior 424B filings in 12m filing 28
Jul 27, 2026 Offering (424B) 424B3 prospectus supplement 2026-07-27; 1 prior 424B filings in 12m filing 28
Jul 24, 2026 Shelf filed S-1/A filed 2026-07-24 filing 30
Jul 24, 2026 Reverse split “reverse split” language in PRE 14A (PRE 14A) filed 2026-07-24 filing 27
Jul 24, 2026 Shelf effective EFFECT notice 2026-07-24 filing 21
Jul 24, 2026 Shelf effective EFFECT notice 2026-07-24 filing 21
Mar 31, 2026 Runway < 6 months ~3.7 months runway: liquidity $7,278,000 as of 2026-03-31, burn $23,686,000/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing 37
Mar 31, 2026 Near $5M MVLS floor Public float $3,800,000 (as of 2025-06-30) vs $5M Nasdaq MVLS floor; needs price x shares confirmation filing 28
Mar 31, 2026 Cash < current liabilities Liquidity $7,278,000 vs current liabilities $40,686,000 filing 21
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans